24/7 Market News Snapshot 20 Jun 2024 – Nexalin Technology, Inc. Common Stock (NASDAQ: NXL)

June 20, 2024 7:37

Press Release

DENVER, Colo., 20 June, 2024 (247marketnews.com) – (Nasdaq:NXL) are discussed in this article.
Nexalin Technology, Inc. (NXL) has been making waves in the market, with its common stock soaring to $1.365 in the pre-market session, indicating a notable 32.69% increase from market open and a substantial trading volume of 4.1M. This bullish trend has caught the attention of investors looking for growth opportunities, positioning NXL as a lucrative prospect in the current market environment.

In a significant development, Nexalin Technology, Inc. has achieved a groundbreaking milestone with the issuance of a new patent by the U.S. Patent and Trademark Office (USPTO). The recently awarded U.S. Patent No 12,011,591 acknowledges the Company’s innovative work in the realm of non-invasive brain stimulation technology, particularly focusing on its Deep Intracranial Frequency Stimulation (DIFS®) medical device tailored for Alzheimer’s and dementia-related brain disorders.

Titled “Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) Method for Alzheimer’s and Dementia,” the patent underscores Nexalin Technology, Inc.’s dedication to advancing neurological healthcare solutions. The patented Gen-2 and Gen-3 brain stimulation devices utilize a proprietary frequency-based waveform, offering pain-free and precise treatment for patients suffering from cognitive disorders.

This achievement reaffirms Nexalin Technology, Inc.’s position as a frontrunner in healthcare innovation and highlights its commitment to enhancing patient outcomes in the neurology space. The Company’s relentless pursuit of excellence and cutting-edge technology sets it apart as a trailblazer in the evolving landscape of medical technology.

For more information on Nexalin Technology, Inc. and its transformative advancements in brain stimulation technology, interested parties are encouraged to visit the Company’s official website and follow updates on its pioneering work in revolutionizing neurological healthcare.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 Market News, Inc Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.